Drug Shortage Report for VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP

Last updated on 2023-04-05 History
Report ID 168502
Drug Identification Number 02139383
Brand name VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP
Common or Proper name VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) VANCOMYCIN
Strength(s) 1G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 20 mL
ATC code J01XA
ATC description OTHER ANTIBACTERIALS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-08-15
Estimated end date Unknown
Actual end date 2023-04-01
Shortage status Resolved
Updated date 2023-04-05
Company comments This product will be placed on allocation. Contract customers will be allocated 100% of historical monthly demand.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2023-04-05 French Compare
v3 2023-04-05 English Compare
v2 2022-09-01 French Compare
v1 2022-09-01 English Compare

Showing 1 to 4 of 4